Cheng Nuo, Zhang Hao, Zhang Shiyan, Ma Xiaodan, Meng Guoyu
Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui-Jin Hospital, Shanghai JiaoTong University School of Medicine and School of Life Sciences and Biotechnology, Shanghai, Shanghai JiaoTong University, 197 Ruijin Er Road, Shanghai 200025, People's Republic of China.
Acta Crystallogr F Struct Biol Commun. 2021 Apr 1;77(Pt 4):105-112. doi: 10.1107/S2053230X21003150. Epub 2021 Mar 31.
AGAP1 is often considered to regulate membrane trafficking, protein transport and actin cytoskeleton dynamics. Recent studies have shown that aberrant expression of AGAP1 is associated with many diseases, including neurodevelopmental disorders and acute lymphoblastic leukemia. It has been proposed that the GTP-binding protein-like domain (GLD) is involved in the binding of cofactors and thus regulates the catalytic activity of AGAP1. To obtain a better understanding of the pathogenic mechanism underpinning AGAP1-related diseases, it is essential to obtain structural information. Here, the GLD (residues 70-235) of AGAP1 was overexpressed in Escherichia coli BL21 (DE3) cells. Affinity and gel-filtration chromatography were used to obtain AGAP1 with high purity for crystallization. Using the hanging-drop vapor-diffusion method with the protein at a final concentration of 20 mg ml, AGAP1 protein crystals of suitable size were obtained. The crystals were found to diffract to 3.0 Å resolution and belonged to space group I4, with unit-cell parameters a = 100.39, b = 100.39, c = 48.08 Å. The structure of AGAP1 exhibits the highly conserved functional G1-G5 loops and is generally similar to other characterized ADP-ribosylation factor (Arf) GTPase-activating proteins (GAPs), implying an analogous function to Arf GAPs. Additionally, this study indicates that AGAP1 could be classified as a type of NTPase, the activity of which might be regulated by protein partners or by its other domains. Taken together, these results provide insight into the regulatory mechanisms of AGAP1 in cell signaling.
AGAP1通常被认为可调节膜运输、蛋白质转运和肌动蛋白细胞骨架动力学。最近的研究表明,AGAP1的异常表达与许多疾病相关,包括神经发育障碍和急性淋巴细胞白血病。有人提出,GTP结合蛋白样结构域(GLD)参与辅因子的结合,从而调节AGAP1的催化活性。为了更好地理解AGAP1相关疾病的致病机制,获取结构信息至关重要。在此,AGAP1的GLD(第70 - 235位氨基酸残基)在大肠杆菌BL21(DE3)细胞中过表达。采用亲和层析和凝胶过滤层析以获得高纯度的AGAP1用于结晶。使用悬滴气相扩散法,使蛋白质终浓度为20mg/ml,获得了尺寸合适的AGAP1蛋白晶体。发现这些晶体的衍射分辨率为3.0Å,属于空间群I4,晶胞参数a = 100.39,b = 100.39,c = 48.08Å。AGAP1的结构呈现出高度保守的功能性G1 - G5环,并且总体上与其他已表征的ADP - 核糖基化因子(Arf)GTP酶激活蛋白(GAP)相似,这意味着其功能与Arf GAP类似。此外,本研究表明AGAP1可被归类为一种NTP酶,其活性可能受蛋白质伴侣或其其他结构域的调节。综上所述,这些结果为AGAP1在细胞信号传导中的调节机制提供了见解。